Cerity Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$351K Sell
15,772
-11,957
-43% -$286K ﹤0.01% 2501
2025
Q4
$741K Sell
27,729
-6,834
-20% -$163K ﹤0.01% 1861
2025
Q3
$738K Buy
34,563
+18,620
+117% +$440K ﹤0.01% 1750
2025
Q2
$344K Sell
15,943
-644
-4% -$12K ﹤0.01% 2073
2025
Q1
$276K Sell
16,587
-3,872
-19% -$70.3K ﹤0.01% 2064
2024
Q4
$349K Buy
20,459
+6,173
+43% +$99.6K ﹤0.01% 1962
2024
Q3
$220K Buy
+14,286
New +$238K ﹤0.01% 2260
2024
Q2
Sell
-12,992
Closed -$240K 2222
2024
Q1
$240K Buy
+12,992
New +$322K ﹤0.01% 1999
2021
Q3
Sell
-15,664
Closed -$382K 684
2021
Q2
$382K Sell
15,664
-5,000
-24% -$113K 0.01% 519
2021
Q1
$533K Buy
20,664
+15,000
+265% +$660K 0.01% 438
2020
Q4
$303K Buy
+5,664
New +$281K 0.01% 515

Other funds holding ACAD